FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084459309> ?p ?o ?g. }

• W2084459309 endingPage "535" @default.
• W2084459309 startingPage "525" @default.
• W2084459309 abstract "Transplantation of adrenal medulla cells has been proposed in the treatment of various conditions. Indeed, these cells possess a bipotentiality: neural and neuroendocrine, which could be exploited for brain repair or pain therapy. In a previous study, we characterized these human cells in vitro over 7-10 gestational weeks (GW) [Zhou, H., Aziza, J., Sol, J.C., Courtade-Saidi, M., Chatelin, S., Evra, C., Parant, O., Lazorthes, Y., and Jozan, S., 2006. Cell therapy of pain: Characterization of human fetal chromaffin cells at early adrenal medulla development. Exp. Neurol. 198, 370-381]. We report here our results on the extension to 23 GW. This developmental period can be split into three stages. During the first stage (7-10 GW), we observed in situ that extra-adrenal surrounding cells display the same morphology and phenotype as the intra-adrenal chromaffin cells. We also found that the intra-adrenal chromaffin cells could be committed in vitro towards an adrenergic phenotype using differentiating agents. During the second stage (11 to 15-16 GW), two types of cells (Type 1 and Type 2 cells) were identified morphologically both inside and outside the gland. Interestingly, we noted that the Type 2 cells stem from the Type 1 cells. However, during this developmental period only the intra-adrenal Type 2 cells will evolve towards an adrenergic phenotype. In the third stage (17-23 GW), we observed the ultimate location of the medulla gland. Both the in situ results and the in vitro experiments indicate that particular procedures need to be implemented prior transplantation of chromaffin cells. First, in order to obtain a large number of immature chromaffin cells, they must be isolated from the intra and extra-adrenal gland and should then be committed towards an adrenergic phenotype in vitro for subsequent use in pain therapy. This strategy is under investigation in our laboratory." @default.
• W2084459309 created "2016-06-24" @default.
• W2084459309 creator A5001057194 @default.
• W2084459309 creator A5028051956 @default.
• W2084459309 creator A5044163348 @default.
• W2084459309 creator A5048135316 @default.
• W2084459309 creator A5055431095 @default.
• W2084459309 creator A5068446063 @default.
• W2084459309 creator A5075439177 @default.
• W2084459309 creator A5076213722 @default.
• W2084459309 creator A5091508287 @default.
• W2084459309 date "2007-06-01" @default.
• W2084459309 modified "2023-09-26" @default.
• W2084459309 title "Human fetal chromaffin cells: A potential tool for cell pain therapy" @default.
• W2084459309 cites W1410493678 @default.
• W2084459309 cites W1527297582 @default.
• W2084459309 cites W1564030924 @default.
• W2084459309 cites W1600867266 @default.
• W2084459309 cites W1917454445 @default.
• W2084459309 cites W1964982163 @default.
• W2084459309 cites W1970469146 @default.
• W2084459309 cites W1972525015 @default.
• W2084459309 cites W1975427773 @default.
• W2084459309 cites W1984950880 @default.
• W2084459309 cites W1986307397 @default.
• W2084459309 cites W1986535356 @default.
• W2084459309 cites W1987396302 @default.
• W2084459309 cites W1987506486 @default.
• W2084459309 cites W1996770323 @default.
• W2084459309 cites W2000299259 @default.
• W2084459309 cites W2001872186 @default.
• W2084459309 cites W2002256716 @default.
• W2084459309 cites W2007259597 @default.
• W2084459309 cites W2013315235 @default.
• W2084459309 cites W2024141414 @default.
• W2084459309 cites W2029603916 @default.
• W2084459309 cites W2041793749 @default.
• W2084459309 cites W2048745570 @default.
• W2084459309 cites W2051618688 @default.
• W2084459309 cites W2053723119 @default.
• W2084459309 cites W2054587340 @default.
• W2084459309 cites W2054673364 @default.
• W2084459309 cites W2057403086 @default.
• W2084459309 cites W2059524959 @default.
• W2084459309 cites W2067017215 @default.
• W2084459309 cites W2075646809 @default.
• W2084459309 cites W2081879522 @default.
• W2084459309 cites W2083145700 @default.
• W2084459309 cites W2084908578 @default.
• W2084459309 cites W2090941527 @default.
• W2084459309 cites W2094221707 @default.
• W2084459309 cites W2106809514 @default.
• W2084459309 cites W2125253111 @default.
• W2084459309 cites W2126755481 @default.
• W2084459309 cites W2129907352 @default.
• W2084459309 cites W2131135142 @default.
• W2084459309 cites W2137979524 @default.
• W2084459309 cites W2143265447 @default.
• W2084459309 cites W2161916703 @default.
• W2084459309 cites W2421047322 @default.
• W2084459309 cites W2441151731 @default.
• W2084459309 cites W4251930006 @default.
• W2084459309 doi "https://doi.org/10.1016/j.expneurol.2007.03.020" @default.
• W2084459309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17466976" @default.
• W2084459309 hasPublicationYear "2007" @default.
• W2084459309 type Work @default.
• W2084459309 sameAs 2084459309 @default.
• W2084459309 citedByCount "22" @default.
• W2084459309 countsByYear W20844593092012 @default.
• W2084459309 countsByYear W20844593092013 @default.
• W2084459309 countsByYear W20844593092014 @default.
• W2084459309 countsByYear W20844593092015 @default.
• W2084459309 countsByYear W20844593092018 @default.
• W2084459309 countsByYear W20844593092019 @default.
• W2084459309 crossrefType "journal-article" @default.
• W2084459309 hasAuthorship W2084459309A5001057194 @default.
• W2084459309 hasAuthorship W2084459309A5028051956 @default.
• W2084459309 hasAuthorship W2084459309A5044163348 @default.
• W2084459309 hasAuthorship W2084459309A5048135316 @default.
• W2084459309 hasAuthorship W2084459309A5055431095 @default.
• W2084459309 hasAuthorship W2084459309A5068446063 @default.
• W2084459309 hasAuthorship W2084459309A5075439177 @default.
• W2084459309 hasAuthorship W2084459309A5076213722 @default.
• W2084459309 hasAuthorship W2084459309A5091508287 @default.
• W2084459309 hasConcept C104317684 @default.
• W2084459309 hasConcept C10882517 @default.
• W2084459309 hasConcept C126322002 @default.
• W2084459309 hasConcept C126749454 @default.
• W2084459309 hasConcept C127716648 @default.
• W2084459309 hasConcept C134018914 @default.
• W2084459309 hasConcept C142724271 @default.
• W2084459309 hasConcept C1491633281 @default.
• W2084459309 hasConcept C172680121 @default.
• W2084459309 hasConcept C189014844 @default.
• W2084459309 hasConcept C196843134 @default.
• W2084459309 hasConcept C202751555 @default.
• W2084459309 hasConcept C2775894120 @default.
• W2084459309 hasConcept C2777597313 @default.

• next